OMADA HEALTH INC SEC Filings

Sean P. Duffy, Omada Health insider sale disclosed. The filing shows that on 09/05/2025 Mr. Duffy, who serves as Chief Executive Officer and a Director, disposed of 4,413 shares of Omada Health common stock at a price of $24.28 per share. After the sale his reported direct beneficial ownership is 140,323 shares. The filing also reports 861,109 shares held indirectly in family trusts for the benefit of his family, which he disclaims beneficial ownership of except to the extent of any pecuniary interest. The Form 4 was signed by an attorney-in-fact on 09/09/2025.

Omada Health insider sale: The Form 4 shows Wei-Li Shao, President and officer of Omada Health, sold 2,407 shares of common stock on 09/05/2025 at a price of $24.28 per share. After the sale, Shao beneficially owned 76,540 shares, reported as direct ownership. The filing was signed by an attorney-in-fact on 09/09/2025.

Omada Health, Inc. Schedule 13G shows that a set of related reporting persons (U.S. Venture Partners X, L.P.; USVP X Affiliates, L.P.; Presidio Management Group X, L.L.C.; and Casey M. Tansey) report collective beneficial ownership of the company's common stock. The filings report 4,571,769 shares held directly by USVP X and an additional 146,257 shares held by USVP X Affiliates, for a combined reported position of 4,718,026 shares. The filing states this represents approximately 8.2% of the outstanding common stock based on 57,574,921 shares of common stock outstanding used for the calculation. The reporting persons disclaim group status and clarify that Presidio Management Group X, L.L.C. acts as general partner and certain named individuals may be deemed to share voting and dispositive power, while each disclaims beneficial ownership except to the extent of any pecuniary interest.

The filing is a Schedule 13G disclosing that Andreessen Horowitz-related entities and principals report beneficial ownership in Omada Health, Inc. (OMDA) as of June 30, 2025. Andreessen Horowitz Fund IV, L.P. directly holds 4,210,602 shares (reported as 7.6% of the class) and AH Parallel Fund IV, L.P. directly holds 403,972 shares (reported as 0.7% of the class), producing an aggregate reported position of 4,614,574 shares, equal to 8.3% of outstanding common stock based on 55,744,340 shares outstanding per the issuer prospectus dated June 5, 2025. The filing identifies Andreessen and Horowitz as individuals with shared voting and dispositive power over the aggregated holdings and includes powers of attorney and a joint filing agreement.

Revelation-affiliated entities and two managing members reported beneficial ownership positions in Omada Health's common stock. Michael Boggs and Scott Halsted each report beneficial ownership of 5,208,034 shares, representing 9.1% of the outstanding stock, while Revelation Healthcare Fund IV reports 3,095,306 shares (5.4%). Several Revelation entities report smaller positions (0.9%–2.3%).

The statement shows these reporting persons have sole voting and sole dispositive power over the shares disclosed and uses a public share count of 56,929,340 shares to calculate percentages. The filing is a disclosure of ownership levels by related funds and their managers; it does not announce transactions, changes in control, or other operational developments within the company.

Omada Health reported accelerating commercial growth with materially stronger liquidity following its IPO. Revenue rose to $61.4 million for the quarter and $116.3 million for the six months, increases of 49% and 52% year-over-year, driven by services and connected-device sales. Gross profit expanded while operating loss narrowed to $4.3 million for the quarter and $12.7 million for six months, reflecting higher revenue and continued investment in R&D, sales and marketing, and G&A.

The company closed an IPO that generated $151.6 million of net proceeds and converted all redeemable convertible preferred stock into common shares, leaving cash and cash equivalents of $223.1 million and eliminating prior preferred-stock balances and related warrant liabilities. Omada reported over 752,000 enrolled members and maintains a $30.0 million term facility (repaid subsequent to period). Despite improved liquidity and revenue momentum, the company remains loss-making with a substantial accumulated deficit.